Skip to main content
. 2021 Mar 15;48(7):2086–2096. doi: 10.1007/s00259-021-05277-4

Fig. 1.

Fig. 1

Synopsis of the clinical validity of tau PET ligands of the THK family as adapted from an oncology framework [2, 4]